Novo Nordisk stock reversed a three-day downtrend Wednesday after the weight-loss drugs kingpin leaned on Ozempic for a fourth-quarter beat.

A consultant, an artist, a model, and a former staffer to the Surgeon General walk into a wine bar to decide what’s in and ...